Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1966 7
1967 8
1968 22
1969 21
1970 26
1971 30
1972 41
1973 50
1974 62
1975 106
1976 68
1977 80
1978 81
1979 114
1980 124
1981 115
1982 136
1983 157
1984 216
1985 202
1986 211
1987 249
1988 276
1989 332
1990 366
1991 340
1992 373
1993 367
1994 393
1995 431
1996 398
1997 440
1998 503
1999 410
2000 441
2001 394
2002 440
2003 500
2004 483
2005 488
2006 450
2007 465
2008 457
2009 538
2010 547
2011 524
2012 571
2013 567
2014 652
2015 598
2016 672
2017 670
2018 681
2019 606
2020 257
Text availability
Article attribute
Article type
Publication date

Search Results

16,842 results
Results by year
Filters applied: . Clear all
Page 1
Marcaine for augmentation mammaplasty.
Rosenblatt WB. Rosenblatt WB. Plast Reconstr Surg. 2011 Feb;127(2):1009; author reply 1009-10. doi: 10.1097/PRS.0b013e318200ad53. Plast Reconstr Surg. 2011. PMID: 21285833 No abstract available.
Bupivacaine, levobupivacaine and ropivacaine: are they clinically different?
Casati A, Putzu M. Casati A, et al. Best Pract Res Clin Anaesthesiol. 2005 Jun;19(2):247-68. doi: 10.1016/j.bpa.2004.12.003. Best Pract Res Clin Anaesthesiol. 2005. PMID: 15966496 Review.
Two new, long-acting local anaesthetics have been developed after the evidence of bupivacaine-related severe toxicity: levobupivacaine and ropivacaine. ...Evaluating randomised, controlled trials that have compared these three local anaesthetics, this chapter supports the …
Two new, long-acting local anaesthetics have been developed after the evidence of bupivacaine-related severe toxicity: levobupivacain …
The effect of Marcaine on muscle and non-muscle cells in vitro.
Schultz E, Lipton BH. Schultz E, et al. Anat Rec. 1978 Jul;191(3):351-69. doi: 10.1002/ar.1091910308. Anat Rec. 1978. PMID: 677489
The effect of the local anaesthetic Marcaine on muscle and non-muscle cell types was examined using an in vitro assay. Each of the cell types examined (myotubes, myoblasts, fibroblasts and liver parenchyma) expressed morphological alterations when incubated in Marcaine
The effect of the local anaesthetic Marcaine on muscle and non-muscle cell types was examined using an in vitro assay. Each of the ce …
Intravenous regional analgesia and the Marcaine story.
Seed RF. Seed RF. Middle East J Anaesthesiol. 1985 Jun;8(2):109-24. Middle East J Anaesthesiol. 1985. PMID: 3900644 Review. No abstract available.
[Anti-arrhythmia properties of marcaine].
Dzhaparidze MM, Berdiaev SIu, Darinskiĭ NV, Senova ZP, Liubushkina TE. Dzhaparidze MM, et al. Biull Eksp Biol Med. 1983 Sep;96(9):64-7. Biull Eksp Biol Med. 1983. PMID: 6616058 Russian.
Comparative study of antiarrhythmic properties of marcaine and lidocaine was made on aconitine- and strophanthine-induced experimental arrhythmias and in rhythm disorders induced by electrical stimulation of the ventricles. ...Toxic effects of marcaine do not make c …
Comparative study of antiarrhythmic properties of marcaine and lidocaine was made on aconitine- and strophanthine-induced experimenta …
Levobupivacaine.
McClellan KJ, Spencer CM. McClellan KJ, et al. Drugs. 1998 Sep;56(3):355-62; discussion 363-4. doi: 10.2165/00003495-199856030-00005. Drugs. 1998. PMID: 9777312 Review.
Levobupivacaine 75 to 122 mg was less arrhythmogenic than the same dose range of bupivacaine in healthy volunteers. Its effects on the corrected QT interval were significantly weaker than those of bupivacaine, and it tended to have a weaker effect on QRS duration. . …
Levobupivacaine 75 to 122 mg was less arrhythmogenic than the same dose range of bupivacaine in healthy volunteers. Its effects on th …
Levobupivacaine.
McLeod GA, Burke D. McLeod GA, et al. Anaesthesia. 2001 Apr;56(4):331-41. doi: 10.1046/j.1365-2044.2001.01964.x. Anaesthesia. 2001. PMID: 11284819 Free article. Review.
Bupivacaine (Marcaine): an evaluation of its tissue and systemic toxicity in humans.
Moore DC, Mather LE, Bridenbaugh LD, Thompson GE, Balfour RI, Lysons DF, Horton WG. Moore DC, et al. Acta Anaesthesiol Scand. 1977;21(2):109-21. doi: 10.1111/j.1399-6576.1977.tb01201.x. Acta Anaesthesiol Scand. 1977. PMID: 848254
In countries other than the U.S.A., dosages of bupivacaine have been limited to 100 mg without epinephrine and 150 mg with epinephrine. A review of 7,688 regional block procedures employing bupivacaine in concentrations of 0.25, 0.5, and 0.75%, and in dosages …
In countries other than the U.S.A., dosages of bupivacaine have been limited to 100 mg without epinephrine and 150 mg with epi …
Evaluation of the effect of Bupivacaine (Marcaine) in reducing early post tonsillectomy pain.
Bukhari MA, Al-Saied AS. Bukhari MA, et al. Saudi Med J. 2012 Nov;33(11):1201-4. Saudi Med J. 2012. PMID: 23147877 Clinical Trial.
OBJECTIVE: To evaluate the effectiveness of bupivacaine as topically applied in reducing post tonsillectomy pain within the first 24 hours. ...CONCLUSION: Topical application of bupivacaine at a 0.25% concentration appears to a considerable degree of analgesia withi …
OBJECTIVE: To evaluate the effectiveness of bupivacaine as topically applied in reducing post tonsillectomy pain within the first 24 …
16,842 results
Jump to page
Feedback